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ABSTRACT
A spontaneous intoxication caused by the anticoagulant rodenticide bromadiolone (Lanirat 0.005) in a 
Caucasian mountain shepherd dog at the age of 18 months is described. During its hospitalization at the Clinic 
of Internal Diseases, Faculty of Veterinary Medicine in Stara Zagora, clinical, laboratory, microbiological, 
radiological and ultrasonographic studies were performed. It was found that rodenticide intoxication was 
manifested by changes in the clinical status (arexia, polydipsia, hyperthermia, polypnea, dyspnea, tachycardia, 
pale conjunctives, liquidothorax and ascites) and in studied laboratory parameters (oligochromaemia, erythropenia, 
leukocytosis with neutrophilia and regenerative shift, hyperglycaemia, increased ALAT activities and prolonged 
PT, APTT and PIVKA).
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Introduction
Pesticides are used all over the world in different branches of agriculture, industry, 
health care, etc. Their wide application and inadequate information about the means of their 
use and their toxic effects pose a real hazard for the health of both animals and humans 
(MARONI et al., 2000).
From the aspect of ecological agriculture the control of harmful rodents (mice, rats, 
field mice, etc) requires precise and adequate use of chemical means of restriction of their 
population. To date, the use of baits containing active substances with various composition 
and anticoagulant effect is the most frequent of such means (SENGALEVICH et al., 1998).
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Anticoagulant rodenticides are probably the most commonly used of such means 
around the world. It has been estimated that approximately 95% of all rodenticides used 
are anticoagulant baits (MURPHY, 2002).
Anticoagulant rodenticides are classified into two principal groups: derivatives of 
coumarin and indanedione. The preparations from the first group are more extensively used 
and provoke severe injury to vascular permeability, resulting in massive haemorrhages and 
the rapid death of rodents (SAMAMA et al., 2002; MURPHY, 2002; RADI and THOMPSON, 
2004).
The mechanism of intoxication with coumarin anticoagulants is via a specific inhibition 
of blood coagulation. Vitamin K is needed for the functional synthesis of coagulation factors 
II, VII, IX and X. The most common vitamin K-responsive coagulopathy is anticoagulant 
rodenticide intoxication (ROZANSKI et al., 1999; SAMAMA et al., 2002; MISCHKE and 
NOLTE, 1999; MOUNT et al., 2003). Blood vessels lose their elasticity, and subsequently 
ruptures of large blood vessels occur, clinically manifested by massive haemorrhages and 
haematomes (PETRUS and HENIK, 1999; KOHN et al., 2003; LUTZE et al., 2003; MUNDEY and 
THOMPSON, 2003; RADI and THOMPSON, 2004). PETTERINO and PAOLO (2001) showed 
that anticoagulant rodenticides impair the cellular recirculation of vitamin K, causing 
secondary coagulopathies.
Up until now cases of intoxication with anticoagulant rodenticides and their effects 
have been described in cats (KOHN et al., 2003), polecats (SHORE et al., 2003), in wild 
animals (deer, coons, marten, eagle, owlet, hawk, etc.) with various anticoagulants such 
as bromadifacoum, chlorophacinone, bromadiolone and coumatetralyl (STONE et al., 1999; 
STONE et al., 2003).
A spontaneous intoxication with an unknown anticoagulant rodenticide in a dog has 
been described by BLOCKER and ROBERTS (1999); ROZANSKI et al. (1999); PETRUS and 
HENIK (1999); PETTERINO and PAOLO (2001); MURPHY (2002); MOUNT et al. (2003); 
MUNDAY and THOMPSON (2003); LUTZE et al. (2003); PETTERINO et al. (2004).
One of the most commonly used rodenticides is bromadiolone, used in the composition 
of the commercial preparation Lanirat 0.005. Bromadiolone is a second-generation 
coumarin anticoagulant. It is used at a dose of 8-10% added to a bait consisting of 100 kg 
ground grain, 1.5 l sunflower oil, 4 l water and 2 l Lanirat 0.005. Thus, it is used to attract 
harmful rodents (SENGALEVICH et al., 1998).
In the available literature there are no complete clinical and laboratory data for 
spontaneous intoxication with bromadiolone in dogs, which motivated our complex 
clinical, laboratory, microbiological, radiological and ultrasonographic studies in order to 
facilitate the diagnostics and the treatment of bromadiolone intoxications.
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Materials and methods
On March 11, 2002 an 18-month-old male Caucasian shepherd dog from Shoumen 
named Spike and weighing 60 kg was referred to the Clinic of Internal Diseases, Faculty 
of Veterinary Medicine, Trakia University, Stara Zagora. Anamnesis revealed that a week 
earlier the owner noticed a symmetrical abdominal enlargement, decreased appetite, frequent 
urination and increased thirst. Three to four weeks previously a deratization by placement 
of baits containing Lanirat 0.005 in farm premises, where the dog was used as a guard, had 
been performed. For some time the dog was occasionally observed eating dead and dying 
rodents. The animal’s diet normally consisted of granulated food and plenty of meat and fats.
Immunoprophylactic and antihelminthic drugs were regularly administered. During the 
period prior to the referral, body temperature increased up to 40 oC. The dog was given 
antibiotics: i.m. Shotapen and 2 000 000 UI Penicillin intraperitoneally, but with no 
effect.
During the hospitalization clinical status was followed twice daily by checking body 
temperature (BT), heart rate (HR) and respiratory rate (RR), colour of mucosae, appetite, 
thirst, general condition, locomotor activity, sensory perception, urination, defecation, etc. 
applying routine clinical diagnostic methods.
At referral and at post-hospitalization days 4, 8, 12 and 16, blood from v. cephalica 
antebrachii was sampled for determination of haemoglobin concentration (HGB), red blood 
cell (RBC) counts, white blood cell (WBC) counts and haematocrit (HCT) (automated 
haemoanalyzer Serono-System 150+, U.S.A.), and differential WBC counts by the method 
of Pappenheim, erythrocyte sedimentation rate (ESR) by the method of Panchenko, 
Thrombin time (TT), activated partial thromboplastine time (APTT), prothrombin time 
(PT), protein induced by Vitamin K antagonism or absence (PIVKA) and activated clotting 
time (ACT) using diagnostic kits (BIOLABO, France), and a coagulometer (Amelung, 
Germany). The activities of transaminases ASAT and ALAT, uric acid, total bilirubin, 
urea, creatinine and blood sugar were assessed using an automated analyser (Reflotron 
Manual, Germany) using a Roche (Germany) diagnostic kit.
The course of the disease and its treatment were followed by thoracic and abdominal 
radiography (TUR D-800-1, Germany) and ultrasonography probe (Aloka-SSD-500, 
UST-5871-5).
Several punctions of the thorax (in the left intercostal spaces VII-VIII and the right 
intercostal spaces IV-V) and the abdomen were performed at hospitalization and post-
hospitalization, on days 3, 6, 9 and 12. Physical analysis of punctate included its colour, 
transparency, density (using an aerometer), with a chemical analysis of the amount of 
protein (Esbach’s albuminometer). The punctate was microscopically and microbiologically 
studied on McConkey agar (blood agar with 5% sheep red blood cells). The Rivolta test 
was applied for differentiating between transudate and exudate.
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Results
The physical examination revealed pale conjunctives, decreased locomotor activity 
and sensory perception, rapid exhaustion, bilateral symmetrical abdominal enlargement 
with drooping of the ventral wall and spinal lordosis. The patient was constantly sitting 
up in order to ease respiration. Body temperature was 39.6 oC, heart rate 115 min-1 and 
respiratory rate – 88 min-1.
Fig. 1. Changes in body temperature (BT), heart rate (HR) and respiratory rate (RR) of a dog fol-
lowing intoxication with the anticoagulant rodenticide bromadiolone.
Parameters Days after the hospitalization
1 3 6 9 12
Amount, mL 1700 500 650 400 250
Density 1,005 1,008 1,010 1,012 1,015
Protein g% 2 2.5 2.5 3 3
Rivolta’s test - - ± ± ±
Sediment Plenty of erythrocytes. Polymorphonuclear leucocytes and endothel cells
During hospitalization (Fig. 1) an elevated BT was present during the first two days, 
but afterwards, until the end of the follow-up, it was within physiological range (37.5-
39.0 °C).
A tachycardia was observed from the first (115 min-1) until the 7th (82 min-1) day of 
hospitalization. From day 8 until the end of follow-up, RR was normalized (60-80 min-1). 
Table. 1. Results from the analysis of thoracic punctuates obtained from a dog following intoxica-
tion with anticoagulant rodenticide bromadiolone.
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The pulse was strong, full, hard and rhythmic. After percussion a decrease in absolute 
cardiac dullness was observed, while auscultation revealed stunt cardiac tones.
Breathing at referral was with increased frequency (88 min-1) difficult (with open 
mouth) from a costo-abdominal type, with the active participation of abdominal muscles in 
both respiratory phases. Percussion showed a dullness in the ventral pulmonary areas with 
a horizontal upper limit that moved with lifting of the front part of the body. Auscultation 
evidenced a bronchial respiration with moist fin bubbling rates over the limit of horizontal 
dullness. Underneath, respiratory sounds were poorly audible. The RR was enhanced 
(polypnea) for the whole period of observation (Fig. 1). The tendency towards lower RR 
observed during the second half of the period did not result in normalization and the values 
were still above physiological limits (15-25 min-1).
Fig. 2. Abdominal (left) and thoracic (right) ultrasonographies of a dog following intoxication 
with anticoagulant rodenticide bromadiolone by day 1
Fig. 3. Abdominal (left) and thoracic (right) ultrasonographies of a dog following intoxication 
with anticoagulant rodenticide bromadiolone by day 12
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Parameters Days after the hospitalization
1 4 8 12 16
Haematological parameters
HGB g/L 82 88 98 115 122
RBC T/L 5.19 5.24 5.54 7.39 8.56
HCT % 33.3 35.7 43.4 55.3 61.1
WBC G/L 19.1 15.2 16.4 13.8 12.1
Differential wbc counts %
Eo 0 0 1 1 0
Mm 3 5 3 4 2
St 18 25 14 13 22
Sg 70 64 65 77 62
Lym 8 6 16 5 14
Mo 1 0 1 0 0
Biochemical parameters
Blood sugar mmol/L 6.48 6.23 6.87 5.54 4.82
Total bilirubin µmol/L 28.6 22.8 23.5 18.1 13.2
ASAT U/L 34.1 32.2 20.8 15.0 12.8
ALAT U/L 65.2 54.8 44.2 35.7 40.1
Urea mmol/L 18.8 12.4 9.6 12.8 10.2
Uric acid µmol/L 78,8 64,2 96,5 118,4 128,1
Creatinine µmol/L 148 124 109 111 94
PT s 122 84 36 18 14
APTT s 86 68 24 22 10
PIVKA s 148 96 45 32 15
TT s 18 10 14 15 10
ACT s 82 64 58 75 45
Table. 2. Clinical laboratory blood examinations data of a dog following intoxication with antico-
agulant rodenticide bromadiolone.
Lateral thoracic and abdominal radiographs were performed at referral, which revealed 
shading with a horizontal upper limit.
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Ultrasonography was also performed in order to assess the amount and position of liquid 
in the thoracic and abdominal cavities (Fig. 2). Interpretation suggested vast anechogenic 
spaces (filled with liquid), contrasting with the more echogenic zones of the liver, spleen, 
intestines and the soft abdominal wall. A similar echogenic picture was also observed in 
the pleural cavity.
At day 12, a second ultrasonography was performed (Fig. 3) which evidenced a marked 
decrease inf thoracic and abdominal liquids.
The optimal site of thoracic punction was found using general and special methods and 
was located in the left VIIIth intercostal space in the zone of maximum dullness. During 
hospitalization, 5 thoracic punctions were performed: in left intercostal spaces VII-VIII 
and right intercostal spaces IV-V. The punctate had an intensively red colour and was 
odourless. The results of analysed punctates are presented in Table 1, showing that they 
were haemorrhagic transudates. The microbiologically studied was negative. Similar results 
showed the data of the abdominal punctates.
Laboratory parameters, assessed during the hospitalization period (Table 2), showed 
decreased HGB – 82 g/l, RBC – 5.19 T/l and HCT – 33.3% and increased WBC counts: 
19.1 G/l. By the end of the observation those parameters returned to their physiological 
values. The differential WBC counts suggested neutrophilia with a regenerative shift to 
Mm (3-5%).
Higher blood levels were measured for blood sugar, bilirubin and ALAT. They remained 
elevated until the end of the hospitalization, although a tendency towards normalization 
was observed. Significant deviations in the levels of ASAT, urea, creatinine, uric acid and 
ESR were not observed during the period of study.
Prothrombin time (PT) was 122 s (reference range: 12-14 s), activated partial 
thromboplastine time (APTT) was 88 s (reference range: 12-16 s) and protein induced 
by vitamin K antagonism or absence (PIVKA) was 148 s (reference range: <25 s) at the 
beginning of the period of observation. Following treatment it was restored to within the 
reference range by day 12 of hospitalization. thrombin time (TT) and activated clotting 
time (ACT) was in reference range.
Discussion
Anticoagulant rodenticides impair the cellular recirculation of vitamin K causing 
secondary coagulopathies, inhibits blood coagulation and affects blood vessels via an 
analogous mechanism (BLOCKER and ROBERTS, 1999; PETRUS and HENIK, 1999; MUNDEY 
and THOMPSON, 2003; KOHN et al., 2003). This explains haemocirculatory disorders 
manifested by accumulation of haemorrhagic transudate in thoracic (liquidothorax) and 
abdominal cavity (ascites) (RADI and THOMPSON, 2004), observed by us. It could be 
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presumed that the simultaneous decrease of RBC counts, haemoglobin (normochromic 
anemia) and haematocrit values occurred as a consequence of blood loss. The observed 
leukocytosis and hyperthermia are probably caused by immunodeficiency, which in turn 
resulted in some kind of infection (KATARANOVSKI et al., 2003). Immunodeficiency 
is a consequence of long-term anaemia and hypoxia, as well as liver injury (RADI and 
THOMPSON, 2004). The large amount of thoracic transudate is most likely responsible for 
the collapse of the compressed pulmonary parenchyma and for the signs of respiratory 
insufficiency: polypnea, dyspnea, and costo-abdominal type of breathing. The tachycardia 
is a compensatory mechanism for oligochromaemia, erythropenia and pulmonary 
insufficiency. Hyperglycaemia, bilirubinaemia and increased ALAT activity are other 
signs of the toxic effect of anticoagulant rodenticides on liver parenchyma. It could be 
accepted that the same toxicodynamics are also valid for bromadiolone intoxication.
Treatment. Throughout the period of hospitalization (days 1-15), 300 mL 20% glucose, 
5 mL 10% vitamin C, 5 mL 20% coffein natricum benzoicum intravenously and 3 mg/kg 
body weight vitamin K
1
 subcutaneously were administered once daily. Medication therapy 
was extended by intramuscular administration of 12 mL Lincomycin-Spectinomycin 
5/10 (50 mg lincomycin hydrochloride and 100 mg spectinomycin dihydrochloride in 
1 mL injectable solution) (Alfasan-Woerden, Holland) every 24 hours for 10 days; 20 
mg Furosemide (in 2 mL injectable solution) every 12 hours for 3 days, followed by 
oral application of 40 mg Furosemide tablets twice daily for 10 days, and 5 g urotropin 
(hexamethylentetramin) once daily for 7 days.
The punctions of thoracic and abdominal cavities were followed by intrathoracal or 
intraperitoneal administration of 10 mL vitamin AD
3
E, (vitamin A 15000 UI, vitamin 
D
3
 20000 UI and vitamin E 0.01 g), 1 mL gentamicin (40 mg/mL), 5 mL 1% novokain 
(1 g procaine hydrochloride in 100 mL, VetProm, Radomir, Bulgaria) and 1 mL 
dexamethasone (2 mg dexamethasone disodium phosphate in 1 mL; Alfasan-Woerden, 
Holland).
After a 3-week therapy, the clinical and the laboratory status of the patient was within 
reference ranges and the dog was discharged from the clinic as cured.
Anticoagulant rodenticide toxicosis is a potentially fatal condition, but it may be treated 
successfully if diagnosis is made quickly and appropriate therapy is instituted.
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SAŽETAK
Opisano je trovanje antikoagulantnim rodenticidom bromadiolonom (Lanirat 0,005) u kavkaskog planinskog 
ovčara u dobi 18 mjeseci. U tijeku njegova liječenja provedene su kliničke, laboratorijske, mikrobiološke, 
radiološke i ultrazvučne pretrage. Trovanje se očitovalo promjenama u kliničkoj slici (areksija, polidipsija, 
hipertermija, polipneja, dispneja, tahikardija, bljedoća spojnica, likvidotoraks i ascites). Od laboratorijskih 
pokazatelja ustanovljena je oligokromemija, eritropenija, leukocitoza s neutrofilijom i regenerativnim promjenama, 
hiperglikemija, povećana aktivnost ALAT i produženo PT, APTT i PIVKA.
Ključne riječi: trovanje, antikoagulant, rodenticid, bromadiolon, pas 
